NCT01574157View on ClinicalTrials.gov

Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 5, 2012

Primary Completion Date

May 1, 2018

Study Completion Date

May 1, 2018

Conditions

Chronic Renal InsufficiencyDiabetes Mellitus

Interventions

DRUG

Sodium bicarbonate

Participants will receive 0.5 meq of sodium bicarbonate per 1 kilogram of lean body weight daily. The total amount will be divided into twice daily doses.

DRUG

Placebo

Participants will receive an identical number of placebo tablets had they been assigned to the intervention. Placebo will be divided into twice daily doses and receive this for six months.

Trial Locations (1)

84148

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City

All Listed Sponsors

lead

VA Office of Research and Development

FED

NCT01574157 - Investigations of the Optimum Serum Bicarbonate Level in Renal Disease. | Biotech Hunter | Biotech Hunter